Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyman Björklund

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Endocrinology|June 21, 2017
Epigenetics of pheochromocytoma and paragangliomaPeyman Björklund, Samuel Backman
Methods in Molecular Biology (Clifton, N.J.)|November 8, 2011
Culture of parathyroid cellsPeyman Björklund, Per Hellman
Plos Medicine|November 30, 2007
An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signalingPeyman Björklund, Göran Akerström, Gunnar Westin
The Journal of Clinical Endocrinology and Metabolism|October 19, 2006
Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumorsPeyman Björklund, Göran Akerström, Gunnar Westin
Vitamins and Hormones|January 26, 2019
Aldosterone-Producing AdenomasPer Hellman, Peyman Björklund, Tobias Åkerström
World Journal of Surgery|April 18, 2009
Molecular genetics of parathyroid diseaseGunnar Westin, Peyman Björklund, Göran Akerström
Molecular Cancer|June 11, 2008
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patientsPeyman Björklund, Daniel Lindberg, Göran Akerström, et al.
Scientific Reports|June 7, 2018
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survivalRajani Maharjan, Samuel Backman, Tobias Åkerström, et al.
Clinical Endocrinology|February 17, 2007
Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cellsUlrika Segersten, Peyman Björklund, Per Hellman, et al.
Plos One|January 23, 2009
The internally truncated LRP5 receptor presents a therapeutic target in breast cancerPeyman Björklund, Jessica Svedlund, Anna-Karin Olsson, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Endocrinology|June 21, 2017
Epigenetics of pheochromocytoma and paragangliomaPeyman Björklund, Samuel Backman
Methods in Molecular Biology (Clifton, N.J.)|November 8, 2011
Culture of parathyroid cellsPeyman Björklund, Per Hellman
Plos Medicine|November 30, 2007
An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signalingPeyman Björklund, Göran Akerström, Gunnar Westin
The Journal of Clinical Endocrinology and Metabolism|October 19, 2006
Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumorsPeyman Björklund, Göran Akerström, Gunnar Westin
Vitamins and Hormones|January 26, 2019
Aldosterone-Producing AdenomasPer Hellman, Peyman Björklund, Tobias Åkerström
World Journal of Surgery|April 18, 2009
Molecular genetics of parathyroid diseaseGunnar Westin, Peyman Björklund, Göran Akerström
Molecular Cancer|June 11, 2008
Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patientsPeyman Björklund, Daniel Lindberg, Göran Akerström, et al.
Scientific Reports|June 7, 2018
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survivalRajani Maharjan, Samuel Backman, Tobias Åkerström, et al.
Clinical Endocrinology|February 17, 2007
Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cellsUlrika Segersten, Peyman Björklund, Per Hellman, et al.
Plos One|January 23, 2009
The internally truncated LRP5 receptor presents a therapeutic target in breast cancerPeyman Björklund, Jessica Svedlund, Anna-Karin Olsson, et al.
Pageof 5